Bny Mellon Alcentra Fund Current Valuation
| DCFDelisted Fund | USD 9.24 0.00 0.00% |
Valuation analysis of Bny Mellon Alcentra helps investors to measure Bny Mellon's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Bny Mellon's price fluctuation is very steady at this time. At this time, the entity appears to be overvalued. Bny Mellon Alcentra shows a prevailing Real Value of $8.52 per share. The current price of the fund is $9.24. We determine the value of Bny Mellon Alcentra from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor locking in undervalued funds and disposing overvalued funds since, at some point, fund prices and their ongoing real values will blend.
The fair value of the Bny fund is determined by what a typical buyer is willing to pay for full or partial control of Bny Mellon Alcentra. Since Bny Mellon is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bny Fund. However, Bny Mellon's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.24 | Real 8.52 | Hype 9.24 |
The real value of Bny Fund, also known as its intrinsic value, is the underlying worth of Bny Mellon Alcentra Fund, which is reflected in its stock price. It is based on Bny Mellon's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bny Mellon's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bny Mellon Alcentra helps investors to forecast how Bny fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bny Mellon more accurately as focusing exclusively on Bny Mellon's fundamentals will not take into account other important factors: Bny Mellon Alcentra Fund Current Valuation Analysis
Bny Mellon's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Bny Mellon Alcentra has a Current Valuation of 0.0. This indicator is about the same for the average (which is currently at 0.0) family and about the same as High Yield Bond (which currently averages 0.0) category. This indicator is about the same for all United States funds average (which is currently at 0.0).
Bny Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bny Mellon's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the funds which would be a good addition to a portfolio. Peer analysis of Bny Mellon could also be used in its relative valuation, which is a method of valuing Bny Mellon by comparing valuation metrics of similar companies.Bny Mellon is currently under evaluation in current valuation among similar funds.
Bny Fundamentals
| Shares Outstanding | 14.98 M | |||
| Shares Owned By Institutions | 19.77 % | |||
| Number Of Shares Shorted | 16.85 K | |||
| Price To Earning | 30.50 X | |||
| Short Ratio | 0.44 X | |||
| Earnings Per Share | 0.22 X | |||
| Market Capitalization | 90.97 M | |||
| Annual Yield | 0.01 % | |||
| Year To Date Return | 11.12 % | |||
| One Year Return | 17.06 % | |||
| Three Year Return | 5.83 % | |||
| Five Year Return | 7.00 % | |||
| Last Dividend Paid | 0.6 |
About Bny Mellon Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bny Mellon Alcentra's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bny Mellon using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bny Mellon Alcentra based on its fundamental data. In general, a quantitative approach, as applied to this fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any fund could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Bny Fund
If you are still planning to invest in Bny Mellon Alcentra check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bny Mellon's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |